Company / Cash & Equivalents
Rallybio Corp Cash & Equivalents History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$31.4M
FY2025
5-year range
$13.9M / $31.4M
FY2024-FY2025
Trend
+125.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$31M in FY2025.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash & equivalents increased 125.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score 40.31 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.4M | +125.7% |
| FY2024 | $13.9M | - |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026